Clinical Trials Browser

Interventional × Neoplastic Cells, Circulating × Standard of Care × Clear all

NCT06391892 2024-04-30

LIQUIPANC

Phase 3 Recruiting

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms